218 results
Page 7 of 11
DEFM14A
b9eojb3jf sm
6 Nov 18
Proxy related to merger
12:00am
424B3
2bzm02o
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
sfp8mwx r4b
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
7oye8n94w 117e1
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
2qipoxlb3 yodjp
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-2.1
3mb1yknd uv
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
53qi5qnyj1d
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
c41g8kr2
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.1
99icarxzjzop
9 Aug 18
Business combination disclosure
5:17pm
8-K
EX-99.1
qwm87 5tvm
3 May 18
OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update
4:53pm
8-K
1r1pifimh1u2
3 May 18
OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update
4:53pm